Tomovircona

Tomovircona covers the latest news, scientific research, regulatory developments, RNA interference (RNAi) innovations, product commercialization, and crop protection advances related to the world’s newest RNAi-based virucide. Stay informed on RNAi technology, plant virus control, biological crop protection, biotechnology, sustainable agriculture, gene silencing, and agricultural innovation.

Tomovircona is the ISO-approved common name for an RNA interference (RNAi) virucide developed by Silicon Gene Technologies (Shanghai) Co., Ltd. under the development code SG-001. Approved by the ISO 1750 Maintenance Agency in 2026, tomovircona is designed to protect crops against plant viral diseases using double-stranded RNA (dsRNA) technology that specifically targets viral RNA through gene silencing, offering a highly selective and environmentally responsible approach to crop protection. As one of the emerging RNA-based plant protection technologies, tomovircona represents a significant advancement in next-generation biological crop protection, supporting sustainable farming and integrated pest and disease management. This category covers ISO approvals, scientific research, regulatory updates, commercialization, field trials, product launches, RNAi innovations, and global biotechnology developments.

Stay updated on Tomovircona news, RNAi virucides, plant virus management, dsRNA technologies, biological crop protection, agricultural biotechnology, sustainable farming, and global crop protection innovations.